US 11512080
CRBN ligands and uses thereof
granted A61PA61P35/00
Quick answer
US patent 11512080 (CRBN ligands and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kymera Therapeutics, Inc.
- Grant date
- Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P35/00